CLDX CIK: 744218

Celldex Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.55
FY22:
2.26
FY23:
6.58
FY24:
6.82
FY25:
1.35
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.2
FY22:
−115
FY23:
−155
FY24:
−195
FY25:
−287
(positive)
Change from FY24 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−229
FY25:
−313
(positive)
Change from FY21 to FY25
millions USD
FY21:
−70.7
FY22:
−112
FY23:
−141
FY24:
−158
FY25:
−259
(positive)
Change from FY21 to FY25
millions USD
FY21:
−70.5
FY22:
−112
FY23:
−141
FY24:
−158
FY25:
−259

All amounts in millions USD Data sources:SEC EDGARTwelve Data